Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells
Open Access
- 10 June 2002
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 117 (4) , 821-827
- https://doi.org/10.1046/j.1365-2141.2002.03495.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 20 references indexed in Scilit:
- FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remissionBone Marrow Transplantation, 1998
- The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemiaBone Marrow Transplantation, 1997
- Loss of natural killer activity as an indicator of relapse in acute leukaemiaClinical and Experimental Immunology, 1990
- Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.The Journal of Experimental Medicine, 1989
- Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.The Journal of Experimental Medicine, 1988
- Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.The Journal of Experimental Medicine, 1988
- Hoechst 33258: a fluorescent nuclear counterstain suitable for double-labelling immunofluorescenceJournal of Immunological Methods, 1983
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Treatment of Murine Leukaemia with X Rays and Homologous Bone MarrowBMJ, 1956